Exchange: NASDAQ·Updated 07:58 PM EDT
Latest Earnings Results: Q2 '26

Reported: Jul 29

Estimated EPS

-$0.08

Reported EPS

$0.42

Surprise

+625%

Estimated Rev

$29.21M

Reported Rev

$32.61M

Surprise

+11.62%

$ANIK Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.25 up 189.29% YoY • Reported revenue of $32.61M up 15.56% YoY • Anika Therapeutics, Inc. is raising its full-year 2026 revenue growth guidance to 5% to 10% and its adjusted EBITDA margin outlook to 13% to 17% for the fiscal year.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.23
--
--
N/A
Q2 '26
-$0.08
$0.42
625.00%
BEAT
Q1 '26
-$0.07
$0.27
485.71%
BEAT
Q4 '25
-$0.12
$0.31
348.00%
BEAT
Q3 '25
-$0.18
$0.04
122.22%
BEAT

Advertisement|Remove ads.